Biotin and Hepatitis aggravated - a phase IV clinical study of FDA data

Summary:

Hepatitis aggravated is reported as a side effect among people who take Biotin (biotin), especially for people who are female, 50-59 old, also take Sulfasalazine, and have Metastases to bone.

The phase IV clinical study analyzes which people have Hepatitis aggravated when taking Biotin. It is created by eHealthMe based on reports of 33,728 people who have side effects when taking Biotin from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,153 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

33,728 people reported to have side effects when taking Biotin.
Among them, 47 people (0.14%) have Hepatitis aggravated.

Could Biotin cause Hepatitis aggravated?

Among these 47 people:

What is the gender of people who have Hepatitis aggravated when taking Biotin? *

female: 85.37 %
male: 14.63 %

What is the age of people who have Hepatitis aggravated when taking Biotin? *

What are other drugs people take besides Biotin? *

What are other side effects people have besides Hepatitis aggravated? *

Pain: 24 people, 51.06%
Injury: 24 people, 51.06%
Rectal Haemorrhage (bleeding from anus): 23 people, 48.94%
Neoplasm Progression (growth of tumour): 23 people, 48.94%
Sinusitis (inflammation of sinus): 23 people, 48.94%
Hepatic Lesion: 23 people, 48.94%
Atelectasis (partial or complete collapse of the lung): 23 people, 48.94%
Back Pain: 23 people, 48.94%
Stress And Anxiety: 22 people, 46.81%
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 22 people, 46.81%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 21 people, 44.68%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 10.64%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 10.64%
Breast Cancer Metastatic: 4 people, 8.51%
Pain: 3 people, 6.38%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 4.26%
Hiv Infection: 2 people, 4.26%
Depression: 2 people, 4.26%
High Blood Pressure: 2 people, 4.26%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and have Hepatitis aggravated?

- Check whether Hepatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biotin:

Biotin (35,393 reports)

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis aggravated:

Hepatitis aggravated (1,153 drugs)

Browse all the conditions that are associated with Hepatitis aggravated:

Hepatitis aggravated (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on biotin (the active ingredients of Biotin) and Biotin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.